Literature DB >> 21425960

Significance of soluble interleukin-2 receptor in patients with hemophagocytic lymphohistiocytosis.

Lijuan Zhang, Sujiang Zhang, Ji Xu, Yixin Hu, Lingling Wang, Xiaoyan Zhang, Wei Xu, Peng Liu, Hongxia Qiu, Jianyong Li.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425960     DOI: 10.3109/10428194.2011.566394

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  5 in total

1.  Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD.

Authors:  Masayuki Nagasawa; Noriko Mitsuiki; Masakatsu Yanagimachi; Masahide Yamamoto; Tetsuya Fukuda; Osamu Miura; Ryutaro Oba; Akira Igarashi; Kinya Nagata; Tomohiro Morio
Journal:  Int J Hematol       Date:  2021-03-08       Impact factor: 2.490

2.  Association of soluble interleukin-2 receptor alpha with laboratory parameters and clinical findings of hemophagocytic lymphohistiocytosis patients: The first report from South of Iran.

Authors:  Mansoureh Shokripour; Maral Mokhtari; Babak Samizadeh
Journal:  J Educ Health Promot       Date:  2020-02-28

3.  Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen.

Authors:  Lingbo He; Shuyan Yao; Ruoxi Zhang; Menghan Liu; Zhengjie Hua; Heshan Zou; Zhao Wang; Yini Wang
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

4.  A prospective quality improvement initiative in adult hemophagocytic lymphohistiocytosis to improve testing and a framework to facilitate trigger identification and mitigate hemorrhage from retrospective analysis.

Authors:  Samuel A Merrill; Rakhi Naik; Michael B Streiff; Satish Shanbhag; Sophie Lanzkron; Evan M Braunstein; Alison M Moliterno; Robert A Brodsky
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

Review 5.  Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.

Authors:  Raymond Chu; Charmaine van Eeden; Sneha Suresh; Wendy I Sligl; Mohammed Osman; Jan Willem Cohen Tervaert
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.